Pertussis Literature

Brooks JI, Bell CA, Rotondo J, et al. Low levels of detectable pertussis antibody among a large cohort of pregnant women in Canada. Vaccine 2018 (published online Sep 1)

Crowcroft NS, Johnson C, Chen C, et al. Under-reporting of pertussis in Ontario: a Canadian Immunization Research Network (CIRN) study using capture-recapture. PLoS One 2018 May 2;13(5):e0195984

Crowcroft NS, Schwartz KL, Chen C, et al. Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada. 2009-2015. Vaccine 2019 May;37(19):2617-23

Duszynski KM, Pratt NL, Lynch JW, et al. Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality: a population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine 2018 (published online Nov 28)

Fabicius G, Aispuro PM, Bergero P, et al. Pertussis epidemiology in Argentina: trends after the introduction of maternal immunisation. Epidemiol Infect 2018 (published online Apr 15)

Forsyth KD, Tan T, von Konig CHW, et al. Recommendations to control pertussis prioritized relative to economies: a Global Pertussis Initiative update. Vaccine 2018 (published online Oct 15)

Fraj IB, Smaoui H, Zghal M, et al. Seroprevalence of pertussis among healthcare workers: a cross-sectional study from Tunisia. Vaccine 2018 (published online Nov 17)

Gutierrez-Ferman JL, Villarreal-Trevino L, Ramirez-Aranda JM, et al. Emerging of ptxP3 lineage in Bordetella pertussis strains circulating in a population in northeastern Mexico. Epidemiol Infect 2018 (published online Aug 23)

Huang H, Gao P, Gao Z, et al. A big pertussis outbreak in a primary school with a high vaccination coverage in northern China: an evidence of the emerging of the disease in China. Vaccine 2018 (published online Nov 9)

Kahn KE, Black CL, Ding H, et al. Influenza and Tdap vaccination coverage among pregnant women—United States, April 2018. MMWR 2018(Sep 28);67(38):1055-9

Leong RNF, Wood JG, Turner RM, et al. Estimating seasonal variation in Australian pertussis notifications from 1991 to 2016: evidence of spring to summer peaks. Epidemiol Infect 2019 (published online Mar 20)

Loconsole D, De Robertis AL, Morea A, et al. Resurgence of pertussis and emergence of the Ptxp3 toxin promoter allele in south Italy. Pediatr Infect Dis J 2018 May;37(5):126-31

Mbayei SA, Faulkner A, Miner C, et al. Severe pertussis infections in the United States, 2011-2015. Clin Infect Dis 2018 (published online Oct 15)

McHugh L, Marshall HS, Perrett KP, et al. The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum Study. Clin Infect Dis 2018 (published online Nov 23)

Moro PL, Perez-Vilar S, Lewis P, et al. Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines. Pediatrics 2018 (published online Jun 4)

Moro PL, Perez-Vilar S, Lewis P, et al. Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines. Pediatrics 2018 Jul;142(1)

Mosser JF, Gagne-Maynard W, Rao PC, et al. Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study. Lancet 2019 (published online Apr 5)

New S, Winter K, Boyte R, et al. Barriers to receipt of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine among mothers of infants aged <4 months with pertussis—California, 2016. MMWR 2018 Sep 28;67(38):1064-7

Patterson J, Kagina BM, Gold M, et al. Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: a systematic review. Vaccine 2018 (published online Aug 22)

Pitisuttithum P, Chokephaibulkit K, Sirivichayakul C, et al. Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial. Lancet Infect Dis 2018 (published online Sep 25)

Ristic M, Radosavljevic B, Stojanovic VD, et al. Performance of the new clinical case definitions of pertussis in pertussis suspected infection and other diagnoses similar to pertussis. PLoS One 2018 (published online Sep 20)

Romanin V, Acosta AM, Juarez MDV, et al. Maternal vaccination in Argentina: Tdap vaccine effectiveness during pregnancy in preventing pertussis in infants less than 2 months of age. Clin Infect Dis 2019 (published online Mar 16)

Shimizu H, Seki K, Shiga K, et al. Safety and efficacy of DTaP-IPV vaccine use in healthcare workers for prevention of pertussis. Vaccine 2018 (published online Aug 25)

Stein-Zamir C, Sokolov I, Abramson N, et al. Pertussis outbreak in infants and an immunization campaign based on providing pertussis vaccine doses at 6 weeks, 10 weeks, and 14 weeks. Pediatr Infect Dis J 2019 Mar;38(3):e63-4

Toubiana J, Azarnoush S, Bouchez V, et al. Bordetella parapertussis bactermia: clinical expression and bacterial genomics. Open Forum Infect Dis 2019 (published online Mar 7)

Weigand MR, Williams MM, Peng Y, et al. Genomic survey of Bordetella pertussis diversity, United States, 2000-2013. Emerg Infect Dis 2019 Apr;25(4):780-3

Zhou F, Xu J, Black CL, et al. Trends in Tdap vaccination among privately insured pregnant women in the United States, 2009-2016. Vaccine 2019 (published online Feb 27)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»